VRTX News
Vertex Pharmaceuticals Incorporated
$510.08
+$6.83(+1.36%)
61
Overall
60
Value
60
Tech
63
Quality
Market Cap
$129.29B
Volume
1.48M
52W Range
$402.58 - $560.25
Target Price
$572.66
VRTX news: the latest Vertex Pharmaceuticals Incorporated headlines, press releases and market updates, newest first.
Latest VRTX News
- Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
- Vortex Energy Expands Saskatchewan Portfolio with Meadows Project AcquisitionTipRanks Canadian Auto-Generated Newsdesk · Oct 1, 2026
- Citi Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
- Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX)TipRanks Newsroom · Sep 23, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE)TipRanks Newsroom · Sep 22, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $510.08 | +1.4% | 1.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW